FIELD: organic chemistry.
SUBSTANCE: invention relates to the chemistry of organic heterocyclic compounds, namely to a new pyridoxine derivative of formula I, exhibiting antitubercular activity.
EFFECT: invention can find application in medicine and veterinary medicine.
         
      
1 cl, 8 dwg, 6 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| DIMEPHOSPHONE ISONICOTINOYLHYDRAZONE WITH ANTI-TUBERCULOSIS ACTIVITY | 2011 | 
 | RU2457212C1 | 
| DIALKYL(2-METHYL-4-OXOPENT-2-YL)PHOSPHINE OXIDE PYRIDINOYL HYDRAZONES, HAVING ANTITUBERCULOUS ACTIVITY | 2012 | 
 | RU2498990C1 | 
| DIMEPHOSPHONE NICOTINOYLHYDRAZONE POSSESSING ANTI-TUBERCULOSIS ACTIVITY | 2011 | 
 | RU2471787C1 | 
| 5-METHYL-7-(3-NITRO-[1,2,4]TRIAZOL-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE, HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST THE AGENT WITH MULTIPLE DRUG RESISTANCE, AND A METHOD FOR PRODUCTION THEREOF | 2018 | 
 | RU2705591C1 | 
| SYNERGIC ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSERINE AND ZINC CONTAINING CONNECTION | 2016 | 
 | RU2620857C1 | 
| ISONICOTINOYLHYDRAZONES SHOWING ANTITUBERCULOSIS ACTIVITY | 1993 | 
 | RU2054002C1 | 
| 1-[(5-NITROFURAN-2-YL)CARBONYL]-2'-PHENYL-1H,7'H-SPIRO[AZETIDINE-3,5'-FURO[3,4-D]PYRIMIDINE], HAVING ANTI-TUBERCULOSIS ACTIVITY IN WITH RESPECT TO MULTIDRUG-RESISTANT TUBERCULOSIS AGENT, AND METHOD FOR PRODUCTION THEREOF | 2023 | 
 | RU2824815C1 | 
| COMPOUND 1-[(5-NITROFURAN-2-YL)CARBONYL]-2'-CYCLOHEXYL-1H,7'H-SPIRO[AZETIDINE-3,5'-FURO[3,4-D]PYRIMIDINE], HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST MULTIDRUG-RESISTANT TUBERCULOSIS AGENT, AND METHOD FOR PRODUCTION THEREOF | 2023 | 
 | RU2825647C1 | 
| 5-FLUORO-2-(4-ETHOXYCARBONYLDIPIPERAZINE-1-YL)-1,3-BENZOTHIAZINE-4-ONE, WHICH HAS ANTI-TUBERCULOSIS ACTIVITY | 2018 | 
 | RU2663848C1 | 
| 1-[(5-NITROFURAN-2-YL)CARBONYL]-2'-PROPYL-1H,7'H-SPIRO[AZETIDINE-3,5'-FURO[3,4-D]PYRIMIDINE], HAVING ANTI-TUBERCULOSIS ACTIVITY IN WITH RESPECT TO MULTIDRUG-RESISTANT TUBERCULOSIS AGENT, AND METHOD FOR PRODUCTION THEREOF | 2023 | 
 | RU2824817C1 | 
Authors
Dates
2022-05-18—Published
2021-07-16—Filed